Amlodipine in the treatment of hypertension

Norman M Kaplan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This article summarizes data from studies showing the antihypertensive efficacy of amlodipine. Ambulatory monitoring studies have confirmed that once-daily dosing provides 24-h control of blood pressure. Comparative studies have shown amlodipine to have superior antihypertensive efficacy to verapamil and equivalent antihypertensive efficacy to hydrochlorothiazide or atenolol. Studies of amlodipine in combination with other classes of antihypertensive agents show an additive effect with diuretics, β-blockers and angiotensin-converting enzyme inhibitors. These properties, together with the value of once-daily dosing, promise to make amlodipine a very useful agent for the treatment of hypertension.

Original languageEnglish (US)
JournalPostgraduate Medical Journal
Volume67
Issue numberSUPPL. 5
StatePublished - 1991

Fingerprint

Amlodipine
Antihypertensive Agents
Hypertension
Ambulatory Monitoring
Hydrochlorothiazide
Atenolol
Verapamil
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Blood Pressure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Amlodipine in the treatment of hypertension. / Kaplan, Norman M.

In: Postgraduate Medical Journal, Vol. 67, No. SUPPL. 5, 1991.

Research output: Contribution to journalArticle

Kaplan, Norman M. / Amlodipine in the treatment of hypertension. In: Postgraduate Medical Journal. 1991 ; Vol. 67, No. SUPPL. 5.
@article{43c196e903784f9ea95996ba721e1691,
title = "Amlodipine in the treatment of hypertension",
abstract = "This article summarizes data from studies showing the antihypertensive efficacy of amlodipine. Ambulatory monitoring studies have confirmed that once-daily dosing provides 24-h control of blood pressure. Comparative studies have shown amlodipine to have superior antihypertensive efficacy to verapamil and equivalent antihypertensive efficacy to hydrochlorothiazide or atenolol. Studies of amlodipine in combination with other classes of antihypertensive agents show an additive effect with diuretics, β-blockers and angiotensin-converting enzyme inhibitors. These properties, together with the value of once-daily dosing, promise to make amlodipine a very useful agent for the treatment of hypertension.",
author = "Kaplan, {Norman M}",
year = "1991",
language = "English (US)",
volume = "67",
journal = "Postgraduate Medical Journal",
issn = "0032-5473",
publisher = "BMJ Publishing Group",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Amlodipine in the treatment of hypertension

AU - Kaplan, Norman M

PY - 1991

Y1 - 1991

N2 - This article summarizes data from studies showing the antihypertensive efficacy of amlodipine. Ambulatory monitoring studies have confirmed that once-daily dosing provides 24-h control of blood pressure. Comparative studies have shown amlodipine to have superior antihypertensive efficacy to verapamil and equivalent antihypertensive efficacy to hydrochlorothiazide or atenolol. Studies of amlodipine in combination with other classes of antihypertensive agents show an additive effect with diuretics, β-blockers and angiotensin-converting enzyme inhibitors. These properties, together with the value of once-daily dosing, promise to make amlodipine a very useful agent for the treatment of hypertension.

AB - This article summarizes data from studies showing the antihypertensive efficacy of amlodipine. Ambulatory monitoring studies have confirmed that once-daily dosing provides 24-h control of blood pressure. Comparative studies have shown amlodipine to have superior antihypertensive efficacy to verapamil and equivalent antihypertensive efficacy to hydrochlorothiazide or atenolol. Studies of amlodipine in combination with other classes of antihypertensive agents show an additive effect with diuretics, β-blockers and angiotensin-converting enzyme inhibitors. These properties, together with the value of once-daily dosing, promise to make amlodipine a very useful agent for the treatment of hypertension.

UR - http://www.scopus.com/inward/record.url?scp=17744412711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744412711&partnerID=8YFLogxK

M3 - Article

C2 - 1839432

AN - SCOPUS:17744412711

VL - 67

JO - Postgraduate Medical Journal

JF - Postgraduate Medical Journal

SN - 0032-5473

IS - SUPPL. 5

ER -